中国冠心病抗栓治疗的探索与展望

被引:30
作者
韩雅玲
机构
[1] 沈阳军区总医院心内科
关键词
冠心病; 血栓溶解疗法; 血管成形术;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
摘要
抗栓治疗是冠心病治疗的重要基石。实现冠心病抗栓治疗的优化,是心血管医师持续努力的目标之一。目前国内冠心病抗栓领域尚缺少高质量的随机对照临床研究,成为中国冠心病抗栓治疗亟待解决的重要问题。针对我国心血管抗栓治疗大数据研究的现状和东西方人群的差异,笔者所在中心于2012年进行了一些初步探索。本文在总结笔者多年临床研究经验的基础上,从冠心病抗栓治疗的热点、现状及策略探索等方面进行述评。
引用
收藏
页码:255 / 261
页数:7
相关论文
共 13 条
  • [1] 瑞舒伐他汀对糖尿病合并轻、中度肾功能不全患者PCI术后LDL-C水平及心血管事件发生的影响
    吉苏珍
    韩雅玲
    荆全民
    李毅
    赵昕
    王效增
    徐凯
    李晶
    [J]. 解放军医学杂志, 2014, (04) : 259 - 264
  • [2] 美国新版《抗栓治疗和血栓预防指南》心房颤动和瓣膜病的更新解读
    孙艺红
    [J]. 中国实用内科杂志, 2013, 33 (05) : 369 - 371
  • [3] 不同年龄段后循环梗死临床特征及血管形态分析
    陈渊
    陈志
    钟维章
    李吕力
    李晓峰
    肖继东
    [J]. 中国实用内科杂志, 2013, 33 (04) : 296 - 299
  • [5] Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: Evidence from clinic to laboratory
    Liu, Lei
    Li, Jian
    Zhang, Yan
    Zhang, Shenghui
    Ye, Jianqin
    Wen, Zhichao
    Ding, Jianping
    Kunapuli, Satya P.
    Luo, Xinping
    Ding, Zhongren
    [J]. THROMBOSIS RESEARCH, 2014, 134 (04) : 866 - 876
  • [6] A Randomized Comparison of Novel Biodegradable Polymer- and Durable Polymer–Coated Cobalt-Chromium Sirolimus-Eluting Stents.[J].Yaling Han;Bo Xu;Quanmin Jing;Shuzheng Lu;Lixia Yang;Kai Xu;Yi Li;Jing Li;Changdong Guan;Ajay J. Kirtane;Yuejin Yang.JACC: Cardiovascular Interventions.2014, 12
  • [7] Comparison of Dual Versus Triple Antiplatelet Therapy After Drug-Eluting Stent According to Stent Length (from the Pooled Analysis of DECLARE Trials)
    Lee, Seung-Whan
    Lee, Jong-Young
    Ahn, Jung-Min
    Park, Duk-Woo
    Han, Seungbong
    Park, Yong Kyu
    Lee, Woo Seok
    Jang, Jeong Yoon
    Kwon, Chang Hee
    Park, Gyung-Min
    Cho, Young-Rak
    Kim, Won-Jang
    Kang, Soo-Jin
    Kim, Young-Hak
    Lee, Cheol Whan
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (11) : 1738 - 1744
  • [8] Differential Impact of Cilostazol on Restenosis According to Implanted Stent Type (from a Pooled Analysis of Three DECLARE Randomized Trials).[J].Seung-Whan Lee;Jung-Min Ahn;Seungbong Han;Gyung-Min Park;Young-Rak Cho;Woo-Seok Lee;Jeong-Yoon Jang;Chang-Hee Kwon;Jong-Young Lee;Won-Jang Kim;Soo-Jin Kang;Young-Hak Kim;Cheol-Whan Lee;Jae-Joong Kim;Seong-Wook Park;Seung-Jung Park.The American Journal of Cardiology.2013,
  • [9] Effect of the CYP2C19*2 and *3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention
    Tang, Xiao-Fang
    Wang, Jing
    Zhang, Jia-Hui
    Meng, Xian-Min
    Xu, Bo
    Qiao, Shu-Bin
    Wu, Yong-Jian
    Chen, Jue
    Wu, Yuan
    Chen, Ji-Lin
    Gao, Run-Lin
    Yuan, Jin-Qing
    Yang, Yue-Jin
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (05) : 1103 - 1112
  • [10] Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.[J].Lanning Zhang;Yanming Chen;Ying Jin;Fei Qu;Jiayue Li;Cong Ma;Jie Yang;Bin Xu;Hongjuan Wang;Xiaoqi Li;Yang Li;Yuxiao Zhang;Caiyi Lu;Tong Yin.Thrombosis Research.2013,